Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.50
22.11.21
-
22.11.22
-2.83%
28.11.21

Risky Investment
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.75
17.11.21
€50.00
17.11.22
4.64%
27.11.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.97
15.11.21
-
15.11.22
-28.16%
26.11.21

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.25
17.11.21
€37.50
30.11.22
-19.46%
18.11.21

Could be very worthwhile Investment >20% year
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.08
20.05.20
€4.50
04.11.21
56.99%
05.11.21

Could be worthwhile Investment >10% per year
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.01
28.04.20
€1.00
04.11.21
35.05%
05.11.21

Could be very worthwhile Investment >20% year
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€13.53
30.03.20
€29.00
04.11.21
72.28%
05.11.21

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€7.15
26.03.20
-
04.11.21
10.29%
05.11.21

Could be very worthwhile Investment >20% year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€2.80
04.01.20
-
04.11.21
112.50%
05.11.21

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€18.00
21.12.19
€30.00
04.11.21
-36.06%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.29
25.11.19
-
04.11.21
196.12%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.85
08.02.19
€21.00
04.11.21
372.71%
05.11.21

buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.89
15.09.21
€5.85
15.09.22
1.27%
22.10.21

Could be very worthwhile Investment >20% year
Future proof or reliable business model
Higher risks for its business
buy
THC Biomed International Inc.

Start price
Target price
Perf. (%)
€0.070
17.04.20
-
04.11.21
-21.43%
14.10.21

buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€8.50
13.10.22
-1.14%
13.10.21

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€8.53
20.09.21
-
20.09.22
-27.86%
02.10.21

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
buy
ESSA Pharma Inc

Start price
Target price
Perf. (%)
€6.85
16.08.21
-
16.08.22
-0.73%
22.08.21

Risky Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.95
05.08.21
-
05.08.22
23.44%
08.08.21

Could be worthwhile Investment >10% per year
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
07.09.20
-
04.11.21
-21.91%
15.07.21

Could be very worthwhile Investment >20% year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€4.64
01.05.21
€4.50
01.05.22
-30.60%
11.06.21

Could be worthwhile Investment >10% per year
buy
LexaGene Holdings Inc.

Start price
Target price
Perf. (%)
€0.92
11.02.21
€2.00
11.02.22
-52.92%
20.04.21